[Familial Mediterranean fever]

Klin Padiatr. 2001 Mar-Apr;213(2):86-8. doi: 10.1055/s-2001-12882.
[Article in German]

Abstract

Background: Familial Mediterranean fever (FMF) is characterized by febrile attacks, acute abdominal pain, pleuritis or arthritis and predominantly observed in ethnic groups of the Mediterranean area (Sephardic Jews, Turks, Armenians). Its most ominous manifestation is amyloidosis potentially leading to chronic renal failure. FMF is an inherited disorder caused by mutations of the FMF-gene, which first was described in 1997.

Case report: We report a 10-year old turkish boy and his family presenting with an increased blood sedimentation rate (WBC) and recurrent attacks of acute abdominal pain. A molecular analysis was carried out, confirming a typical mutation of the FMF-gene. The patient remained free of symptoms after starting therapy with colchicine.

Conclusion: Investigation of the FMF gene enables an early diagnosis in case of clinical suspect findings, subsequent colchicine administration may prevent amyloidosis.

Publication types

  • Case Reports

MeSH terms

  • Abdominal Pain / etiology
  • Blood Sedimentation
  • Child
  • Chromosomes, Human, Pair 18 / genetics*
  • Colchicine / therapeutic use
  • Cytoskeletal Proteins
  • Diagnosis, Differential
  • Familial Mediterranean Fever* / blood
  • Familial Mediterranean Fever* / diagnosis
  • Familial Mediterranean Fever* / drug therapy
  • Familial Mediterranean Fever* / ethnology
  • Familial Mediterranean Fever* / genetics
  • Gout Suppressants / therapeutic use
  • Homozygote
  • Humans
  • Male
  • Mutation*
  • Proteins / genetics*
  • Pyrin
  • Turkey / ethnology

Substances

  • Cytoskeletal Proteins
  • Gout Suppressants
  • MEFV protein, human
  • Proteins
  • Pyrin
  • Colchicine